Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.8M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
74M
-
Shares change
-
-13.9M
-
Total reported value, excl. options
-
$183M
-
Value change
-
-$43.1M
-
Put/Call ratio
-
0.62
-
Number of buys
-
45
-
Number of sells
-
-81
-
Price
-
$2.47
Significant Holders of ACELYRIN, Inc. - Common Stock (SLRN) as of Q1 2025
151 filings reported holding SLRN - ACELYRIN, Inc. - Common Stock as of Q1 2025.
ACELYRIN, Inc. - Common Stock (SLRN) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74M shares
of 99.8M outstanding shares and own 74.12% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (9.82M shares), AyurMaya Capital Management Company, LP (9.33M shares), BlackRock, Inc. (5.81M shares), T. Rowe Price Investment Management, Inc. (4.65M shares), Madison Avenue Partners, LP (4.14M shares), VANGUARD GROUP INC (4.08M shares), ORBIMED ADVISORS LLC (4M shares), venBio Partners LLC (3.81M shares), Velan Capital Investment Management LP (3.37M shares), and TYBOURNE CAPITAL MANAGEMENT (HK) LTD (2.91M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.